| |
|
|
|
Catabasis Pharmaceuticals Inc.  
|
|
6.44 -0.05 (-0.01%) |
07-10 16:00 |
|
Open: |
6.45 |
Pre close: |
6.49 |
Target:
|
8.31
|
|
High: |
6.51 |
Low: |
6.3268 |
Resistance:
|
7.11
7.73
|
|
Volume: |
77,030 |
Market Cap: |
115M |
Support:
|
6.11
5.08
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.61
 |
MACD |
MACD(12,26):
|
0.03 |
|
MA(20): |
6.87  |
Signal(12,26,9): |
0.13 |
|
MA(100): |
5.51 |
Stochastic Oscillator |
%K(14,3):
|
18.26 |
|
MA(250): |
5.69 |
%D(3): |
24.51 |
|
Average Volume(K) |
3-Month: |
21466
|
52-Week |
High:
|
7.73 |
|
10-Days: |
45734 |
Low: |
2.74 |
|
RSI |
RSI(14):
|
45.11 |
Change(%): |
-13.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.210 |
Return on Equity (ttm) |
-54.5 |
Shares Out. (M) |
17.90 |
|
EPS Est. Current Year |
-1.390 |
Return on Assets (ttm) |
-31.7 |
Shares Float (M) |
16.95 |
|
EPS Est. Next Year |
-1.100 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.57 |
|
EPS Est. Next Quarter |
-0.330 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
40.87 |
|
Forward EPS |
-2.350 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
378 |
|
Book Value (p.s.) |
3.000 |
EBITDA (p.s.) |
-1.607 |
P/E |
-2.91 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.15 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-26.97 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-16.92 |
P/CF |
-4.27 |
|
|
|
|
|
|
